Veterans Affairs Center for Clinical Practice Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI 48113-0170, USA.
Med Care. 2010 Feb;48(2):87-94. doi: 10.1097/MLR.0b013e3181c12e53.
It is well-documented that the financial burden of out-of-pocket expenditures for prescription drugs often leads people with medication-sensitive chronic illnesses to restrict their use of these medications. Less is known about the extent to which such cost-related medication underuse is associated with increases in subsequent hospitalizations and deaths.
We compared the risk of hospitalizations among 5401 and of death among 6135 middle-aged and elderly adults with one or more cardiovascular diseases (diabetes, coronary artery disease, heart failure, and history of stroke) according to whether participants did or did not report restricting prescription medications because of cost.
A retrospective biannual cohort study across 4 cross-sectional waves of the Health and Retirement Study, a nationally representative survey of adults older than age 50. Using multivariate logistic regression to adjust for baseline differences in sociodemographic and health characteristics, we assessed subsequent hospitalizations and deaths between 1998 and 2006 for respondents who reported that they had or had not taken less medicine than prescribed because of cost.
Respondents with cardiovascular disease who reported underusing medications due to cost were significantly more likely to be hospitalized in the next 2 years, even after adjusting for other patient characteristics (adjusted predicted probability of 47% compared with 38%, P < 0.001). The more survey waves respondents reported cost-related medication underuse during 1998 to 2004, the higher the probability of being hospitalized in 2006 (adjusted predicted probability of 54% among respondents reporting cost-related medication underuse in all 4 survey waves compared with 42% among respondents reporting no underuse, P < 0.001). There was no independent association of cost-related medication underuse with death.
In this nationally representative cohort, middle-aged and elderly adults with cardiovascular disease who reported cutting back on medication use because of cost were more likely to report being hospitalized over a subsequent 2-year period after they had reported medication underuse. The more extensively respondents reported cost-related underuse over time, the higher their adjusted predicted probability of subsequent hospitalization.
有大量文献记录表明,人们因需自付药物费用而导致经济负担过重,往往会限制对处方药的使用,从而影响慢性病患者的治疗。但对于因费用问题而减少用药的行为与随后住院和死亡风险增加之间的关系,我们目前还知之甚少。
我们比较了在参加健康与退休研究(一项针对 50 岁以上成年人的全国性调查)的 5401 名患有一种或多种心血管疾病(糖尿病、冠状动脉疾病、心力衰竭和中风病史)的中年和老年患者中,因费用问题限制处方药物使用的患者与未限制药物使用的患者的住院风险;并比较了在 6135 名患有一种或多种心血管疾病的中年和老年患者中,因费用问题限制处方药物使用的患者与未限制药物使用的患者的死亡风险。
这是一项回顾性的、每两年进行一次的队列研究,共涉及健康与退休研究的 4 个横断面波次。我们使用多变量逻辑回归来调整基线社会人口统计学和健康特征差异,评估了在 1998 年至 2006 年期间报告因费用问题而减少药物使用的患者在接下来的 2 年内的住院情况和死亡情况。
患有心血管疾病且因费用问题而减少药物使用的患者在接下来的 2 年内更有可能住院,即使调整了其他患者特征后也是如此(调整后的预测概率为 47%,而未调整的预测概率为 38%,P < 0.001)。在 1998 年至 2004 年期间,报告因费用问题而减少药物使用的患者,其在 2006 年的住院概率越高(在报告在所有 4 次调查波次中均存在因费用问题而减少药物使用的患者中,调整后的预测概率为 54%,而在报告不存在药物使用减少的患者中,调整后的预测概率为 42%,P < 0.001)。因费用问题而减少药物使用与死亡之间没有独立的关联。
在这项具有全国代表性的队列研究中,患有心血管疾病且因费用问题而减少药物使用的中年和老年患者在报告药物使用减少后的随后 2 年内更有可能报告住院。患者报告因费用问题而减少药物使用的次数越多,其调整后的预测住院概率就越高。